Edition:
United Kingdom

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

333.00DKK
15 Aug 2018
Change (% chg)

kr.-8.50 (-2.49%)
Prev Close
kr.341.50
Open
kr.341.10
Day's High
kr.342.10
Day's Low
kr.332.60
Volume
301,916
Avg. Vol
545,280
52-wk High
kr.360.70
52-wk Low
kr.288.70

Latest Key Developments (Source: Significant Developments)

BioAg Alliance Announces Updated Research And Development Pipeline
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - BioAg Alliance::BIOAG ALLIANCE - ANNOUNCED UPDATED RESEARCH AND DEVELOPMENT PIPELINE.BIOAG ALLIANCE - SEES ACCELERON B-300 SAT TO BE APPLIED TO BETWEEN 8-10 MILLION ACRES IN 2018, WHILE ACCELERON B-360 ST SCHEDULED TO ENTER MARKET IN 2019.BIOAG ALLIANCE - IN 2019-2020, PLAN TO LAUNCH PRODUCTS FOR GROWERS OF CORN, OILSEED RAPE AND WHEAT IN EUROPE.  Full Article

Novozymes Appoints Prisca Havranek-Kosicek New CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - NOVOZYMES ::PRISCA HAVRANEK-KOSICEK NEW CFO.  Full Article

Novozymes CEO Sells 50,000 Of Own Shares
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Novozymes ::CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION.  Full Article

Novozymes completes share buyback program
Friday, 10 Nov 2017 

Nov 10 (Reuters) - NOVOZYMES ::‍NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017​.  Full Article

Novozymes Q3 EBIT above expectations at DKK 1.06 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - NOVOZYMES ::‍FULL-YEAR OUTLOOK ADJUSTED​.‍NOW EXPECTS ORGANIC REVENUE GROWTH 3-5% (2-5%)​.NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​.NOW EXPECTS ‍DKK REVENUE GROWTH 2-4% (1-4%)​.NOW EXPECTS ‍EBIT GROWTH 2-4% (1-4%)​.Q3 SALES DKK ‍​3.58 BILLION (REUTERS POLL DKK 3.54 BILLION).Q3 EBIT DKK ‍​1.06 BILLION (REUTERS POLL DKK 1.01 BILLION).Q3 NET PROFIT 819 MILLION (REUTERS POLL DKK 789 MILLION).  Full Article

Novozymes ‍Q2 EBIT at DKK ‍​963 mln, below expectations
Friday, 11 Aug 2017 

Aug 11 (Reuters) - NOVOZYMES ::‍Q2 EBIT MARGIN AT 28.2%, EXCLUDING REORGANIZATION COSTS (Q2 2016: 28.0%)​.Q2 EBIT DKK ‍​963 MILLION (REUTERS POLL DKK 994 MILLION).Q2 NET PROFIT 735 MILLION (REUTERS POLL DKK 764 MILLION).Q2 SALES DKK 3.54 BILLION (REUTERS POLL DKK 3.58 BILLION).MAINTAINS ITS FULL-YEAR ORGANIC SALES GROWTH OUTLOOK OF 2-5%‍​.CONTINUES TO EXPECT HIGHER H2 Y/Y ORGANIC GROWTH RELATIVE TO THE 3% DELIVERED IN H1 Y/Y.UNDERLYING EBIT GROWTH OUTLOOK FOR THE FULL YEAR IS MAINTAINED.  Full Article

Novozymes CFO steps down
Thursday, 15 Jun 2017 

June 15 (Reuters) - NOVOZYMES ::BENNY D. LOFT TO STEP DOWN AS CFO AND EXECUTIVE VICE PRESIDENT.  Full Article

Novozymes Q1 EBIT up at DKK 1.01 billion, in line with expectations
Wednesday, 26 Apr 2017 

April 26 (Reuters) - NOVOZYMES A/S :"GOOD START TO 2017 WITH PROGRESS ON OUR STRATEGIC PRIORITIES.".SALES IN Q1 GREW BY 3% ORGANICALLY AND BY 4% IN DKK.EBIT IN Q1 GREW BY 6%.OUTLOOK FOR 2017 IS MAINTAINED..Q1 EBIT DKK 1.01 BILLION (REUTERS POLL DKK 1.01 BILLION).Q1 SALES DKK 3.74 BILLION (REUTERS POLL DKK 3.69 BILLION).  Full Article

Novozymes, Boehringer announce strategic collaboration in probiotics for poultry hatcheries
Thursday, 30 Mar 2017 

Novozymes A/S : Novozymes and Boehringer Ingelheim announce strategic collaboration in probiotics for poultry hatcheries .Boehringer Ingelheim Animal Health - as part of agreement, co will market and distribute Novozymes' Floramax probiotic product for U.S. poultry industry.  Full Article

Dong Energy to build biogas plant for Novo Nordisk, Novozymes residues
Thursday, 23 Mar 2017 

Dong Energy : Says will in cooperation with Bigadan build a large-scale biogas plant . The plant will reuse residues from production facilities of Novozymes and Novo Nordisk in Kalundborg, Denmark . Construction of the new biogas plant will commence in March 2017, and the plant is scheduled for commissioning already in the spring of 2018 .The biogas plant will have a production capacity of 8 million square metres of natural gas per year, corresponding to the consumption of around 5,000 households.  Full Article

Novozymes says Indian tariffs hits sales in its Monsanto alliance in Q1 -CFO

COPENHAGEN, April 25 Danish enzymes maker Novozymes' posted first-quarter earning slightly above forecasts, but sales through its BioAg alliance with U.S. seeds company Monsanto Co were hit by Indian tariffs, its new CFO said on Wednesday.